Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

U.S. clinical trials of SU-6668 slated for early 1999

Dec. 29, 1998

Isis obtains antisense cancer rights from Genzyme Molecular Oncology

Dec. 28, 1998

First convincing data for extended therapeutic gene expression by human stem cells

Dec. 28, 1998

In vivo safety and efficacy of photodynamic therapy evaluated by Theratechnologies in CML patients

Dec. 28, 1998

Gliadel Wafer approved in Canada and France

Dec. 28, 1998

New cancer-linked gene licensed by Corixa from MIT

Dec. 23, 1998

Preliminary phase II results for Incel + paclitaxel in refractory breast cancer

Dec. 23, 1998

Orphan drug status given to Immunomedics' CEA-Cide pancreatic cancer therapeutic

Dec. 23, 1998

Phase I results with GI-147211 establish MTD; phase II doses recommended

Dec. 22, 1998

Isis and Zeneca to develop novel antisense-based cancer drugs

Dec. 22, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...